Evicenter
MarkdownMedical informationP&T meetings
Rinzimetostat (ORIC-944)

Metastatic castration-resistant prostate cancer previously treated with abiraterone, in combination with darolutamide

Regulatory status
Not announced
Launch
Not announced
Last updated
165 sources

Economic information and modeling reportBudget impact model

Cost assumptions

8 evidence topics · 7 sources

Hospital outpatient payment rates for radiopharmaceuticals, October 2026
HCPCS code and productShort descriptorAPCPayment rateMinimum unadjusted copayment
A9606 radium-223 dichloride (Xofigo)“Radium ra223 dichloride ther”“1745”“$180.422”“$36.09”
A9607 lutetium Lu 177 vipivotide tetraxetan (Pluvicto)“Lutetium lu 177 vipivotide”“9054”“$266.541”“$53.31”
Darolutamide wholesale acquisition cost
Product and packageManufacturerDrug product descriptionWAC effective dateWAC increase amount (USD)WAC after increase (USD)
Nubeqa (darolutamide) 300 mg, 120 tablets“Bayer”“Nubeqa 300 mg tab 120 count”“2026-01-01T00:00:00”“847.20”“15100.80”